August 20, 2015/Neurosciences

Treating Essential Tremor

Common disorder raises uncommon issues for physicians

ET_690x380

Chances are good that you’ll encounter essential tremor (ET) in your primary care practice. It’s the most common movement disorder, affecting all age ranges and as many as 6 to 9 percent of people 60 and older according to prevalence studies.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

But due to embarrassment, fear or normalization, your patients may not volunteer that they’re having problems. That means you’ll have to rely more on observational and interview skills to uncover what’s going on and begin the diagnostic and treatment process, says Cleveland Clinic neurologist Michal Gostkowski, DO. Some advice on how to proceed:

Initial signs

ET involuntary movements most often involve the hands and occur during action, in contrast to Parkinson disease (PD) tremors, which occur at rest. ET patients may try to mask or hide their shaking, so Dr. Gostkowski watches their hands when they’re distracted and listens to vocal tremors, another distinctive ET symptom. He also asks if their activities have changed. ET patients may stop socializing or discontinue hobbies that are affected by their tremors. Those restrictions, in turn, may trigger depression, another indicator to watch for. Also, since alcohol can temporarily dampen ET tremors, sufferers may be vulnerable to alcohol overuse or addiction.

Other diagnostic aids

Though ET has its own complications, your patient’s biggest early concern may be that his or her tremors result from PD. A neurologist can make the definitive diagnosis, but for reassurance’s sake, some simple tests in your office — handwriting and water-pouring ability can help differentiate ET from PD. ET patients’ handwriting is large and scratchy-looking, while PD patients’ rigidity results in smaller and smaller printing (a condition called micrographia). ET patients also have trouble pouring water from one cup to another, a task that PD patients execute without spills because their tremors occur at rest.

Advertisement

Patient questions

Your patients likely will ask what caused their ET and what course their disease will take. Though ET clearly has a strong genetic component, no ET-linked genes have been identified so far, and it is likely that some as-yet unknown environmental cofactors are involved. Tremors tend to become more severe as patients age, with some association between age of ET onset and how quickly ET progresses. Older-onset patients have a faster rate of progression.

Medical treatment

Unfortunately, medications are only modestly effective at reducing ET tremors. The beta-blocker propranolol and the anti-seizure drug primidone are the most studied and seemingly the more beneficial, but each lessens tremor in about half of ET patients. Other ET medications include benzodiazepines and anticholinergics, which should be used cautiously in older patients.

Surgery

Deep brain stimulation (DBS) of the thalamus has shown good results in ET. “It’s a very viable option,” Dr. Gostkowski says. “We expect 70 percent to 80 percent improvement in the tremor in about 90 percent of patients,” with minimal side effects. ET patients and their physicians should consider DBS when tremors begin to impair daily living activities.

Advertisement

Related Articles

brain puzzle with piece missing and female symbol
Latest WAM Grant Recipients Take on Alzheimer’s Disease in Women Across Multiple Fronts

Awards fund research on oxidative targets, immunometabolism, spatial navigation testing and more

sleepless woman looking at clock
Sleep Apnea and Insomnia Are Highly Prevalent and Linked to Disease Worsening in Neuropsychiatric Disorders

Large cohort study suggests need for routine sleep screening as part of neurological care

neuron affected by neuromyelitis optica
Novel Monoclonal Antibodies for NMOSD Show Strong Efficacy and Safety in Real-World Study

Early experience with the agents confirms findings from clinical trials

syringe being prepared for injection
April 15, 2024/Neurosciences/Podcast
Balancing Benefits and Pitfalls of Neurotoxin Injections (Podcast)

Determining the right dose and injecting in the right muscle can be challenging

schematic view of brain connections during an epileptic seizure
April 5, 2024/Neurosciences/Epilepsy
New Insights on the Dynamics of Interictal-to-Ictal Transitions in Epilepsy

Study combines intracranial electrophysiology and SPECT to elucidate the role of hypoperfusion

inflammation on a brain scan with a podcast button overlay
April 2, 2024/Neurosciences/Podcast
Diagnosis and Management of Cerebral Amyloid Angiopathy-Related Inflammation (Podcast)

New research sheds light on a potentially devastating condition that is reversible when properly managed

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

Ad